Mayne Pharma Group Limited (ASX:MYX) Announces 1H FY25 Market Update
Mayne Pharma (ASX:MYX) expects 12-14% revenue growth and a 275-300% EBITDA increase for 1H FY25, driven by key sectors.
Mayne Pharma (ASX:MYX) expects 12-14% revenue growth and a 275-300% EBITDA increase for 1H FY25, driven by key sectors.
WAM Global Limited (ASX:WGB) declares increased fully franked interim and special dividends following strong investment portfolio performance.
JB Hi-Fi Limited (ASX:JBH) reports HY25 results with 9.8% sales growth, increased earnings, and a higher interim dividend.
Janison Education Group Limited (ASX:JAN) releases 1H25 results with 3% revenue growth and a 280% increase in customer pipeline.
State Street Global Advisors Australia Services Limited (ASX:SPY) announces USD and AUD distribution rates, with payments due on 14 February 2025.
PM Capital Global Opportunities Fund Limited (ASX:PGF) announces a 3% revenue growth and 11% profit increase for the half-year ended December 2024.
Collins Foods (ASX:CKF) clarifies Yum! Brands’ Q4 sales growth, addressing comparability issues and regional inclusions.
Godolphin Resources Limited (ASX:GRL) temporarily pauses trading pending further announcements.
Kaiser Reef Limited (ASX:KAU) reports high-grade drilling results at Nova Zone, enhancing mineralisation and informing future mine planning.
NT Minerals Limited (ASX:NTM) reports initial copper and gold assay results from the Twin Peaks Project, unveiling new exploration targets.